Brief: Rezolute Announces Further Evidence Of RZ358’S Efficacy In Tumor-Mediated Hyperinsulinism

Rezolute

11/10/2023 13:06

Oct 11 (Reuters) - Rezolute Inc  RZLT.O :
    * REZOLUTE ANNOUNCES FURTHER EVIDENCE OF RZ358’S EFFICACY IN
TUMOR-MEDIATED HYPERINSULINISM

Source text for Eikon:  ID:nGNXbrm4lq 
Further company coverage:  RZLT.O 

 ((Reuters.Briefs@thomsonreuters.com))